Improved lab screening technique opens door for new pediatric neuroblastoma therapies

February 28, 2014

Neuroblastoma is one of the most common and lethal types of childhood cancers. In a paper published online today in OncoTarget, a researcher at the University of Texas Health Science Center at San Antonio unveils the important role of microRNAs in regulating neuroblastoma development, pointing to new therapeutic possibilities.



Researcher isolates new target for leukemia treatment

February 11, 2014

In a paper published today in Leukemia, a Nature journal, a UT Health Science Center researcher has pinpointed a protein that could play a key, previously unknown role in the development of pediatric AML — promising new information in the quest to treat and cure childhood leukemias.



Voelcker Fund helps scientists shed light on lymphoma causes

December 6, 2013

Support from the Max and Minnie Tomerlin Voelcker Fund is enabling UT Health Science Center at San Antonio researchers to study the biological basis of B-cell lymphoma, one of the most common and aggressive types of cancer.